MedPath

PREFERRED PHARMACEUTICALS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

895

FDA:895

Drug Approvals

Tobramycin

Approval Date
Sep 30, 2025
FDA

topiramate

Approval Date
Sep 30, 2025
FDA

Tizanidine

Approval Date
Sep 30, 2025
FDA

Terazosin hydrochloride

Approval Date
Sep 30, 2025
FDA

topiramate

Approval Date
Sep 30, 2025
FDA

TIZANIDINE HYDROCHLORIDE

Approval Date
Sep 30, 2025
FDA

terazosin

Approval Date
Sep 30, 2025
FDA

Terbinafine

Approval Date
Sep 30, 2025
FDA

Tizanidine

Approval Date
Sep 30, 2025
FDA

Temazepam

Approval Date
Sep 29, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 90
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.